GlassScriptPhysician profile
Jitendra D Patel
NPI 1508915539
$985.95
in general payments reported to CMS, 2019-2025
19 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $126 · 2021: $308 · 2023: $37.74 · 2024: $24.19 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $159.97 | 2025 | Gore Cardioform Septal Occluder |
| Pfizer INC. | $118.57 | 2020-2021 | |
| Amarin Pharma, INC. | $94.02 | 2020-2021 | |
| Glaxosmithkline, LLC. | $93.98 | 2019-2021 | |
| Lilly USA, LLC | $89.95 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.15 | 2019-2021 | |
| Amgen INC. | $60.17 | 2019-2025 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $59.12 | 2019-2021 | |
| Orexo US, INC. | $47.84 | 2020-2021 | |
| Novo Nordisk INC | $26.68 | 2019-2023 | |
| Medtronic, INC. | $24.54 | 2023 | Intellis Adaptivestim |
| Hologic Sales and Service, LLC | $24.19 | 2024 | Aptima |
| Abbvie INC. | $21.09 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.69 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.24 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $14.20 | 2019 | |
| Merck Sharp & Dohme LLC | $14.14 | 2019 | |
| Janssen Biotech, INC. | $13.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jitendra Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.